Intelligence · Clinical Development
Pipeline search results
Programs matching “cetuximab” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 14 pipeline programs matching "cetuximab" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
CETUXIMAB
Disc Medicine
oral squamous cell carcinoma
1 trial -
Cetuximab
Amgen
Metastatic Colorectal Cancer
1 trial -
cetuximab + cisplatin + vinorelbine
Merck KGaA, Darmstadt, Germany
Non Small Cell Lung Cancer (NSCLC)
1 trial -
mCapOX plus Cetuximab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer (CRC)
1 trial -
C225 (cetuximab)
The First People's Hospital of Lianyungang
Nasopharyngeal Carcinoma
1 trial -
CETUXIMAB for ADCC, Colorectal Cancer
Fondazione Telethon ETS
ADCC, Colorectal Cancer
1 trial -
Cetuximab
Merck KGaA, Darmstadt, Germany
Metastatic Colorectal Cancer
1 trial -
Cetuximab
United Therapeutics Europe Ltd
BRAF V600E Negative
1 trial -
Cetuximab
Solid Biosciences
Head and Neck Neoplasm
1 trial -
Cetuximab
Hoffmann-La Roche
Colorectal Cancer
1 trial -
Cetuximab β；Fruquintinib；
Zhejiang University
Colorectal Neoplasms
1 trial -
ENCORAFENIB , CETUXIMAB
The George Institute
Patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC) who had received and responded to a BRAF inhibitor-based treatment.
1 trial -
FEMH-95011
Hospital Authority, Hong Kong
Stomach Neoplasms
1 trial -
cetuximab (Erbitux)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.